The impact of treatment density and molecular weight for fractional laser-assisted drug delivery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. / Haak, Christina S; Bhayana, Brijesh; Farinelli, William A; Anderson, R Rox; Haedersdal, Merete.

I: Journal of Controlled Release, Bind 163, Nr. 3, 2012, s. 335-41.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Haak, CS, Bhayana, B, Farinelli, WA, Anderson, RR & Haedersdal, M 2012, 'The impact of treatment density and molecular weight for fractional laser-assisted drug delivery', Journal of Controlled Release, bind 163, nr. 3, s. 335-41. https://doi.org/10.1016/j.jconrel.2012.09.008

APA

Haak, C. S., Bhayana, B., Farinelli, W. A., Anderson, R. R., & Haedersdal, M. (2012). The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. Journal of Controlled Release, 163(3), 335-41. https://doi.org/10.1016/j.jconrel.2012.09.008

Vancouver

Haak CS, Bhayana B, Farinelli WA, Anderson RR, Haedersdal M. The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. Journal of Controlled Release. 2012;163(3):335-41. https://doi.org/10.1016/j.jconrel.2012.09.008

Author

Haak, Christina S ; Bhayana, Brijesh ; Farinelli, William A ; Anderson, R Rox ; Haedersdal, Merete. / The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. I: Journal of Controlled Release. 2012 ; Bind 163, Nr. 3. s. 335-41.

Bibtex

@article{fed51f13f83e427b94e71829e395590d,
title = "The impact of treatment density and molecular weight for fractional laser-assisted drug delivery",
abstract = "Ablative fractional lasers (AFXL) facilitate uptake of topically applied drugs by creating narrow open micro-channels into the skin, but there is limited information on optimal laser settings for delivery of specific molecules. The objective of this study was to investigate the impact of laser treatment density (% of skin occupied by channels) and molecular weight (MW) for fractional CO(2) laser-assisted drug delivery. AFXL substantially increased intra- and transcutaneous delivery of polyethylene glycols (PEGs) in a MW range from 240 to 4300 Da (Nuclear Magnetic Resonance, p",
author = "Haak, {Christina S} and Brijesh Bhayana and Farinelli, {William A} and Anderson, {R Rox} and Merete Haedersdal",
note = "Copyright {\textcopyright} 2012 Elsevier B.V. All rights reserved.",
year = "2012",
doi = "10.1016/j.jconrel.2012.09.008",
language = "English",
volume = "163",
pages = "335--41",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - The impact of treatment density and molecular weight for fractional laser-assisted drug delivery

AU - Haak, Christina S

AU - Bhayana, Brijesh

AU - Farinelli, William A

AU - Anderson, R Rox

AU - Haedersdal, Merete

N1 - Copyright © 2012 Elsevier B.V. All rights reserved.

PY - 2012

Y1 - 2012

N2 - Ablative fractional lasers (AFXL) facilitate uptake of topically applied drugs by creating narrow open micro-channels into the skin, but there is limited information on optimal laser settings for delivery of specific molecules. The objective of this study was to investigate the impact of laser treatment density (% of skin occupied by channels) and molecular weight (MW) for fractional CO(2) laser-assisted drug delivery. AFXL substantially increased intra- and transcutaneous delivery of polyethylene glycols (PEGs) in a MW range from 240 to 4300 Da (Nuclear Magnetic Resonance, p

AB - Ablative fractional lasers (AFXL) facilitate uptake of topically applied drugs by creating narrow open micro-channels into the skin, but there is limited information on optimal laser settings for delivery of specific molecules. The objective of this study was to investigate the impact of laser treatment density (% of skin occupied by channels) and molecular weight (MW) for fractional CO(2) laser-assisted drug delivery. AFXL substantially increased intra- and transcutaneous delivery of polyethylene glycols (PEGs) in a MW range from 240 to 4300 Da (Nuclear Magnetic Resonance, p

U2 - 10.1016/j.jconrel.2012.09.008

DO - 10.1016/j.jconrel.2012.09.008

M3 - Journal article

C2 - 23000695

VL - 163

SP - 335

EP - 341

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -

ID: 48465975